Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
+9.91M
-
Total reported value, excl. options
-
$566M
-
Value change
-
+$212M
-
Put/Call ratio
-
0.71
-
Number of buys
-
79
-
Number of sells
-
-17
-
Price
-
$23.50
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2015
102 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2015.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 101M outstanding shares and own 23.88% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (2.53M shares), VANGUARD GROUP INC (2.47M shares), WADDELL & REED FINANCIAL INC (2.03M shares), FRANKLIN RESOURCES INC (1.74M shares), JPMORGAN CHASE & CO (1.6M shares), Visium Asset Management, LP (1.57M shares), JANUS CAPITAL MANAGEMENT LLC (1.39M shares), EcoR1 Capital, LLC (1.21M shares), BlackRock Fund Advisors (1.14M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (934K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.